Drug intelligence / Profile preview

Tongqiao Jingxuan Granules

Development stage
Unknown
Lead developer
Jiuhua Huayuan Group Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Tongqiao Jingxuan Granules is a Traditional Chinese Medicine (TCM) developed by Jiuhua Huayuan Pharmaceutical for the treatment of benign paroxysmal positional vertigo (BPPV). Formulated as an innovative TCM (Class 1.1), it is designed to address the TCM syndrome of liver yang transforming into wind (肝阳化风), which is clinically associated with symptoms such as dizziness, vertigo, and nausea. The drug is intended to alleviate vertigo symptoms and reduce residual dizziness following canalith repositioning maneuvers. It received marketing approval from China's National Medical Products Administration (NMPA) in late 2023 based on clinical trials demonstrating its efficacy in improving recovery rates and symptom scores in BPPV patients.

Brand names
Tongqiao Jingxuan Granules
Other names
Tongqiao Jingxuan Keli通窍静眩颗粒

Beyond the preview

Go deeper on Tongqiao Jingxuan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongqiao Jingxuan Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call